Skip to main content
. 2024 Feb 6;14(4):1772–1786. doi: 10.1016/j.apsb.2024.01.020

Table 1.

hMAO inhibitory potency and selectivity of identified compounds.

Compounds Inhibition (IC50)a
SIb
hMAO-B hMAO-A
(Z)-Ligustilide 633.346 ± 341.181 6.063 ± 0.985 0.009
Senkyunolide H 593.668 ± 55.172 107.921 ± 11.931 0.182
Senkyunolide I 302.342 ± 37.001 186.240 ± 8.010 0.616
n-Butylphthalide 112.552 ± 24.240 19.180 ± 3.759 0.170
Chlorogenic acid 69.634 ± 14.365 82.362 ± 14.569 1.183
Vanillin 45.695 ± 2.605 86.090 ± 15.313 1.884
Caffeic acid 33.093 ± 7.566 60.901 ± 5.847 1.840
Sinapic acid 32.783 ± 6.098 32.899 ± 5.705 1.004
Senkyunolide A 27.029 ± 9.316 47.573 ± 8.511 1.760
Ferulic acid 26.899 ± 3.528 35.828 ± 2.228 1.332
Butylidenephthalide 12.123 ± 6.480 96.986 ± 14.286 8.000
Coniferyl ferulate 2.029 ± 0.347 102.439 ± 1.331 50.487
Neocnidilide 0.494 ± 0.132 102.437 ± 13.108 207.362
Sedanolide 0.124 ± 0.033 80.067 ± 15.103 645.702
Rasagiline 0.114 ± 0.015 3.564 ± 0.386 31.263
Safinamide 0.006 ± 0.005 104.202 ± 34.732 17,367
Toloxatone 357.219 ± 22.843 1.438 ± 0.162 0.004
a

Inhibition data are reported as IC50 (μmol/L); the standard error of the mean was always less than ± 5%.

b

SI: selectivity index for the MAO-B isoform, equal to the ratio of IC50(MAO-A)/IC50(MAO-B).